Literature DB >> 7936844

Collection and 28-day storage of human placental blood.

E M Bifano1, R A Dracker, K Lorah, A Palit.   

Abstract

Placental blood was harvested using a novel collection system into packs containing citrate-phosphate-dextrose-adenine and then stored for 28 d. Before and during storage, sterility, adequacy of anticoagulation, blood chemistry, and red cell viability were assessed weekly. The average volume of blood collected was 65 mL (range 30-110 mL) with a 0.42 hematocrit once diluted in anticoagulant. All blood culture specimens were sterile at collection and during storage. Adequate anticoagulation (activated partial thromboplastin time > 90 s) on the day of collection was achieved in 15 specimens, all less than 65 mL of blood volume. Ten specimens, in blood volumes ranging from 65 to 110 mL, had mean activated partial thromboplastin time values of 65.3 +/- 10.2 s. Activated partial thromboplastin time values for all 25 specimens at 1, 2, 3, and 4 wk storage were > 90 s, presumably because of the decline in labile clotting factors after 24 h of storage. Hematocrit, red cell ATP, and red cell shape were maintained during storage. As expected, red cell 2,3-diphosphoglycerate declined and potassium levels rose significantly but were not different than levels reported for adult cells similarly preserved. Based on our results, it appears that placental blood represents a potential source of autologous transfusion for the sick neonate over the first month of life.

Entities:  

Mesh:

Year:  1994        PMID: 7936844     DOI: 10.1203/00006450-199407001-00016

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

1.  Comparison of the Bactec 9240 and BacT/Alert blood culture systems for evaluation of placental cord blood for transfusion in neonates.

Authors:  Stefan Riedel; Alan Junkins; Paul D Stamper; Gretchen Cress; John A Widness; Gary V Doern
Journal:  J Clin Microbiol       Date:  2009-04-15       Impact factor: 5.948

Review 2.  Is there a role for autologous/placental red blood cell transfusions in the anemia of prematurity?

Authors:  Ronald G Strauss; John A Widness
Journal:  Transfus Med Rev       Date:  2010-04

3.  Accelerated removal of antibody-coated red blood cells from the circulation is accurately tracked by a biotin label.

Authors:  Donald M Mock; Gary L Lankford; Nell I Matthews; Leon F Burmeister; Daniel Kahn; John A Widness; Ronald G Strauss
Journal:  Transfusion       Date:  2011-10-24       Impact factor: 3.157

4.  Autologous umbilical cord blood transfusion.

Authors:  A Ballin; E Arbel; G Kenet; M Berar; D Kohelet; A Tanay; H Zakut; D Meytes
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-11       Impact factor: 5.747

5.  Red blood cell transfusions in newborn infants: Revised guidelines.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

Review 6.  When to transfuse preterm babies.

Authors:  E F Bell
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-07-24       Impact factor: 5.747

7.  Allogeneic cord blood red blood cells: assessing cord blood unit fractionation and validation.

Authors:  Maria Bianchi; Nicoletta Orlando; Ombretta Barbagallo; Sabrina Sparnacci; Caterina Giovanna Valentini; Brigida Carducci; Luciana Teofili
Journal:  Blood Transfus       Date:  2020-11-03       Impact factor: 3.443

8.  Cardiopulmonary Bypass Priming Using Autologous Cord Blood in Neonatal Congenital Cardiac Surgery.

Authors:  Eun Seok Choi; Sungkyu Cho; Woo Sung Jang; Woong-Han Kim
Journal:  Korean Circ J       Date:  2016-09-28       Impact factor: 3.243

9.  The quality of stored umbilical cord and adult-donated whole blood in Mombasa, Kenya.

Authors:  Oliver Hassall; Kathryn Maitland; Gregory Fegan; Johnstone Thitiri; Lewa Pole; Robert Mwakesi; Douglas Denje; Kongo Wambua; Kishor Mandaliya; Imelda Bates
Journal:  Transfusion       Date:  2009-11-13       Impact factor: 3.157

10.  Comparison of stored umbilical cord blood and adult donor blood: transfusion feasibility.

Authors:  Rola Sahyoun Tokan; Saadet Arsan; Omer Erdeve; Nuri Solaz; Aslıhan Avcı; Serenay Elgün Ulkar; Elif Gülyapar; Zeynep Ustünyurt; Zeynep Bıyıklı; Sabri Kemahlı
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.